Aditxt, Inc. (ADTX) vs Moolec Science SA (MLEC)

Aditxt, Inc. and Moolec Science SA are both Biotechnology companies. Aditxt, Inc. and Moolec Science SA are of similar size ($4.4M and $4.3M). Moolec Science SA has the higher net margin (−7.18% vs −372,998.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Moolec Science SA leads on 9 and Aditxt, Inc. on 4.

Valuation

Metric ADTX MLEC Biotechnology median
P/E n/m n/m 7.88
P/S n/m 0.00 11.47
P/B n/m 0.10 2.52
Price to free cash flow n/m 0.08 21.16
EV/EBITDA n/m 1.79 0.74
EV/Sales 65.38 0.14 10.73
Earnings yield 0.00% (1,399.59%) (28.84%)
Free cash flow yield 0.00% 1,260.08% (23.03%)

Profitability

Metric ADTX MLEC Biotechnology median
Gross margin 20.28% 39.67% 65.16%
Operating margin (128,143.36%) 4.09% 0.00%
Net margin (372,998.60%) (7.18%) 0.00%
Free cash flow margin (129,979.72%) 0.00% 0.00%
Return on equity 549.59% 0.00% (57.72%)
Return on assets (236.38%) 0.00% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ADTX MLEC Biotechnology median
Revenue growth (TTM) (74.19%) — 5.64%
EPS growth (last fiscal year) 99.99% (447.53%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADTX MLEC Biotechnology median
Debt to equity 0.00 4.37 0.00
Current ratio 0.06 0.15 4.73
Net debt to EBITDA 0.18 (2.73) 0.96

Dividend

Metric ADTX MLEC Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ADTX MLEC Biotechnology median
Market cap 4.39m 4.25m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack